34. 神経線維腫症 Neurofibromatosis Clinical trials / Disease details

臨床試験数 : 137 / 薬物数 : 213 - (DrugBank : 76) / 標的遺伝子数 : 87 - 標的パスウェイ数 : 200

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05130866 (ClinicalTrials.gov)	December 1, 2021	10/11/2021	Efficacy and Safety of REC-2282in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated M ...	A Parallel-group, Two-staged, Phase 2/3, Randomized, Multicenter Study to Evaluate the Efficacy and ...	Neurofibromatosis Type 2	Drug: REC-2282;Drug: Placebo	Recursion Pharmaceuticals Inc.	NULL	Not yet recruiting	12 Years	N/A	All	89	Phase 2/Phase 3	NULL

First Previous1Next Last